Abstract
Nitric oxide (NO) participates in the pathogenesis of inflammatory reactions in many autoimmune diseases such as rheumatoid arthritis (RA). There is a reciprocal pathway between arginase and nitric oxide synthese (NOS) for NO production, and Mn is required for arginase activity and stability. To investigate whether NO production related with the arginine-nitric oxide pathway in patients with RA, we measured synovial fluid and plasma nitrite (NOx) levels, arginase activities, and its cofactor manganese (Mn) concentrations in 21 RA patients and 13 healthy control subjects. Plasma albumin levels were measured as an index of nutritional status. NOx levels were determined after the reduction of nitrates to nitrites using the Griess reaction. Whereas, synovial fluid arginase activities and Mn levels were found to be significantly lower (p<0.001, p<0.001, respectively), plasma arginase activities and Mn levels were similar in patients with RA when compared to the control subjects. Plasma and synovial fluid NO levels were similar in patients with RA and in healthy subjects (p>0.05, p>0.05, respectively). There were significantly positive correlations between synovial fluid and plasma arginase activities vs Mn content (r=0.543, p=0.011; r=0.516, p=0.017, respectively) and significantly negative correlations between synovial fluid and plasma NO levels vs arginase activities (r=−0.497, p=0.022; r=−0.508, p=0.019 respectively) in the patients group. Our results indicate that the lower concentration of synovial fluid Mn could cause lower arginase activity and this could also upregulate NO production by increasing L-arginine content in patients with RA.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
D. Recklies, A. R. Poole, S. Banerjee, et al., Pathophysiologic aspects of inflammation in diarthroidal joints, in Orthopaedic Basic Science, 2nd ed., J. A. Buckwalter, T. A. Einhorn, and S. R. Simon, eds., AAOS, Rosemont, IL, pp. 489–530 (2000).
D. O. Stichtenoth and J. C. Frolich, Nitric oxide and inflammatory joint diseases, Br. J. Rheumatol. 37, 246–257 (1998).
A. J. Farrell, D. R. Blake, and R. M. J. Palmar, Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219–1222 (1992).
H. Kolb and V. Kolb-Bachofen, Nitric oxide: a pathogenetic factor in autoimmunity, Immunol. Today 13, 157–159 (1992).
M. Stefanovic-Racic, J. Stadler, and C. H. Evans, Nitric oxide and arthritis, Arthritis Rheum. 36, 1036–1044 (1993).
O. Onur, A. S. Akinci, F. Akbiyik, and I. Unsal, Elevated levels of nitrate in rheumatoid arthritis, Rheumatol. Int. 20, 154–158 (2001).
Y. Ersoy, E. Ozerol, O. Baysal, et al., Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, Ann. Rheum. Dis. 61, 76–78 (2002).
Choi JW, Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin. Chim. Acta 336, 83–87 (2003).
Y. Ueki, S. Miyake, Y. Taminaga, and K. Eguchi, Increased nitric oxide levels in patients with rheumatoid arthritis, J. Rheumatol. 23, 230–236 (1996).
S. Moncada and A. Higgs, The l-arginine nitric oxide pathway, N. Engl. J. Med. 30, 2002–2012 (1993).
C. H. Evans, M. Stefanovic-Racic, and J. Lancaster, Nitric oxide and its role in orthopaedic disease, Clin. Orthop 312, 275–294 (1995).
J. Stadler, M. Stefanovic-Racic, and T. R. Billiar, Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolisaccharide, J. Immunol. 147, 3915–3920 (1991).
G. A. Murrell, M. M. Doland, D. Jang, C. Szabo, R. F. Warren, and J. A. Hannafin, Nitric oxide: an important articular free radical. J. Bone Joint Surg. Am. 78, 265–274 (1996).
J. Cedergren, T. Forslund, T. Sundqvist, and T. Skogh, Inducible nitric oxide synthase is expressed in synovial fluid granulocytes, Clin. Exp. Immunol. 130, 150–155 (2002).
J. L. Boucher, C. Moali, and J. P. Tenu, Nitric oxide biosynthesis, nitric oxide synthase inhibitors an arginase competition for l-arginine utilization. Cell. Mol. Life Sci. 55, 1015–1028 (1999).
J. E. Albina, C. D. Mills, W. L. Henry, and M. D. Caldwell, Temporal expression of different pathways of l-arginine metabolism in healing wounds, J. Immunol. 144, 3877–3880 (1990).
I. Durak, H. S. Ozturk, S. Elgun, M. Y. B. Cimen, and S. Yalcin, Erythrocyte nitric oxide metabolism in patients with chronic renal failure. Clin. Nephrol. 55, 460–464 (2001).
A. Jahnsen, S. Lewis, V. Cattell, and H. T. Cook, Arginase is major pathway of l-arginine metabolism in nephritic glomeruli. Kidney Int. 42, 1107–1112 (1992).
I. Corraliza and S. Moncada, Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide. J. Rheumatol. 29, 2261–2265 (2002).
A. Brock, S. A. Chapman, E. A. Ulman, and G. Wu, Dietary manganese deficiency decreases rat hepatic arginase activity. J. Nutr. 124, 340–344 (1994).
A. M. Diez, M. L. Campo, and G. Soler, Trypsin digestion of arginase: evidence for a stable confirmation manganese directed, Int. J. Biochem. 24, 1925–1932 (1992).
F. C. Arnett, S. M. Edworthy, D. A. Bloch, et al., The American Rheumatisim Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315–324 (1988).
D. O. Stichtenoth, J. Fauler, H. Zeidler, and J. C. Frolich, Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone, Ann. Rheum. Dis. 54, 820–824 (1995)
E. J. Van Kampen and W. G. Zijlstra, Haemoglobinometry: from estimation to reference method, J. Clin. Chem. Clin. Biochem. 19, 517–519 (1981).
W. R. Tracey, J. Tse, and G. Carter, Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272, 1011–1015 (1995).
J. W. Geyer and D. Dabich, Rapid method for determination of arginase activity in tissue homogenates, Anal. Biochem. 39, 412–417 (1971).
L. M. Silverman and R. H. Christenson, Amino acid and proteins, In Textbook of Clinical Chemistry, C. A. Burtis and E. R. Ashwood, eds., Saunders, Philadelphia, pp. 695–697 (2000).
D. Milde, O. Novak, V. Stuka, K. Vyslouil, and J. Machaek, Plasma levels of selenium, manganese, copper, and iron in colorectal cancer patients. Biol. Trace Element Res. 79, 107–114 (2001).
M. Yazar, S. Sarban, A. Kocyigit, and U. E. Isikan, Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol. Trace Element Res. 106, 123–132 (2005).
S. Sarban, A. Kocyigit, M. Yazar, and U. E. Isikan, Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis, Clin. Biochem. 38, 981–986 (2005).
D. Tsikas, F. M. Gutzki, S. Rossa, et al., Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry. Anal. Biochem. 244, 208–220 (1997).
H. Sakurai, H. Kohsaka, M. F. Liu, et al., Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96, 2357–2363 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarban, S., Isikan, U.E., Kocabey, Y. et al. Relationship between synovial fluid and plasma manganese, arginase, and nitric oxide in patients with rheumatoid arthritis. Biol Trace Elem Res 115, 97–106 (2007). https://doi.org/10.1007/BF02686022
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02686022